Volume 5•Issue 3

Aim: To compare effectiveness of angiotensin-converting enzyme inhibitors (ACEis)/angiotensin receptor blockers (ARBs) for protecting Type 2 diabetes mellitus (DM2) patients from renal function decline in a real-world setting. Methods: Retrospective ...

Aims: The purpose of this study was to estimate the incidence and hospital costs associated with hypoglycemic episodes (HEs) requiring hospital admission or emergency room (ER) visits in Denmark. Materials & methods: This study analyzed data from the ...

Background: Association between thrombosis pathogenesis and inflammatory conditions has been reported. Also inflammatory biomarkers have been proposed for prediction of thrombosis events. Objectives: Effects of different methods of heparin ...

Aim: Compare within site effects of three interventions designed to enhance outcomes of hospitalized cognitively impaired elders. Methods: Prospective, nonrandomized, confirmatory phased study. In Phase I, 183 patients received one of three ...

Aim: To compare daclatasvir + asunaprevir (DCV + ASV) versus sofosbuvir/ledipasvir (SOF/LDV) for hepatitis C virus genotype 1b in Japanese patients without NS5A polymorphisms at L31 and Y93H. Patients & methods: All Phase III trials of SOF/LDV and DCV + ...

Background: Statins reduce cardiovascular risk, especially in patients with hypertension due to their concomitant blood pressure reducing effects. Prescribing generic statins minimizes cost and improves access. Aims: Ascertain current prescribing of ...

Research is inconclusive as to whether placebo interventions can result in clinical improvement. A number of methodological concepts must be taken into consideration when estimating differential effects of placebo interventions. Using network meta-...

In response to the creation of the Patient-Centered Outcomes Research Institute in 2010, researchers have begun to incorporate patient and family stakeholders into the research process as equal partners, bringing their unique perspectives and experiences ...

There is increasing attention in the US healthcare system on the delivery of high-quality care, an issue central to oncology. In the report ‘Crossing the Quality Chasm’, the Institute of Medicine identified six aims for improving healthcare quality: safe,...